Photodiagnostic techniques for the endoscopic detection of premalignant gastrointestinal lesions

Digestive Endoscopy

Volumn 15, Issue 3, 2003, Pages 153-173

  DaCosta, Ralph S ^a   Wilson, Brian C ^a   Marcon, Norman E ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Dysplasia; Endoscopy; Fluorescence; Optical imaging; Spectroscopy

Indexed keywords

CANCER DIAGNOSIS; CANCER MORTALITY; CANCER STAGING; CANCER SURVIVAL; CHROMOENDOSCOPY; CONFOCAL FLUORESCENCE ENDOSCOPY; DEVELOPED COUNTRY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIGESTIVE SYSTEM CANCER; DIGESTIVE SYSTEM INJURY; DYSPLASIA; FLUORESCENCE ENDOSCOPIC IMAGING; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL ENDOSCOPY; HIGH RISK POPULATION; HUMAN; IMMUNOFLUORESCENCE ENDOSCOPY; LIGHT SCATTERING SPECTROSCOPY; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL ENDOSCOPIC IMAGING; PHOTODIAGNOSTIC IMAGING; PRECANCER; QUALITY OF LIFE; RAMAN SPECTROMETRY; REVIEW; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY; WHITE LIGHT ENDOSCOPY;

EID: 0041822409     PISSN: 09155635     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-1661.2003.00239.x     Document Type: Review

References (98)

1. DaCosta RS, Lilge L, Kost J et al. Confocal fluorescence microscopy/macroscopy and microspectrofluorimetry analysis of human colorectal tissues. J. Anal. Morph. 1997; 4: 24-9.
2. Zonios GI, Cothren RM, Arendt JT et al. Morphological model of human colon tissue fluorescence. IEEE Trans. Biomed. Eng. 1996; 43: 113-22.
3. Marchesini R, Pignoli E, Tomatis S et al. Ex vivo optical properties of human colon tissue. Lasers Surg. Med. 1994; 15: 351-7.
4. Cothren RM, Richards-Kortum R, Sivak MV et al. Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopy. Gastrointest. Endosc. 1990; 36: 105-11.
5. Panjepour M, Overholt BF, Vo-Dinh T, Haggitt RC, Edwards DA, Buckley FR III. Endoscopic fluorescence detection of high-grade dysplasia in Barrett's esophagus. Gastroenterology 1996; 111: 93-101.
6. Krammer B, Uberriegler K. In-vitro investigation of ALA-induced protoporphyrin IX. J. Photochem. Photobiol. B 1996; 36: 121-6.
7. Kennedy JC, Marcus SL, Pottier RH. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): mechanisms and clinical results. J. Clin. Laser Med. Surg. 1996; 14: 289-304.
8. Baumgartner R, Huber RM, Schulz H et al. Inhalation of 5-aminolevulinic acid: a new technique for fluorescence detection of early stage lung cancer. J. Photochem. Photobiol. B 1996; 36: 169-74.
9. Leveckis J, Burn JL, Brown NJ, Reed MW. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. J. Urol. 1994; 152 (2 Part 1): 550-3.
10. Loh CS, Vernon D, MacRobert AJ, Bedwell J, Bown SG, Brown SB. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. J. Photochem. Photobiol. B 1993; 20: 47-54.
11. Peng Q, Berg K, Moan J, Kongshaug M, Nesland JM. 5-Aminolevulinic acid-based photodynamic therapy-principles and experimental research. Photochem. Photobiol. 1997; 65: 235-51.
12. Martin A, Tope WT, Grevelink JC et al. Lack of selectivity of protoporphyrin-IX fluorescence for basal-cell carcinoma after topical application of 5-aminolevulinic acid: implications for photodynamic treatment. Arch. Dermat. Res. 1995; 287: 665-74.
13. Loh CS, MacRobert AJ, Bedwell J, Regula J, Krasner N, Bown SG. Oral versus intravenous administration of 5′-aminolaevulinic acid for photodynamic therapy. Br. J. Cancer 1993; 68: 41-51.
14. Battle AMC. Porphyrins, porphyrias, cancer and photodynamic therapy: a model of carcinogenesis. J. Photochem. Photobiol. 1993; B20: 5-22.
15. Rick K, Sroka R, Stepp H et al. Pharmacokinetics of 5′ -Aminolevulinic acid-induced protoporphyrin IX in skin and blood. J. Photochem. Photobiol. B 1997; 40: 313-19.
16. Webber J, Kessel D, Fromm D. Side effects and photosensitization of human tissue after aminolevulinic acid. J. Surg. Res. 1997; 68: 31-7.
17. Lange N, Jichlinski P, Zellweger M et al. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study. Br. J. Cancer 1999; 80: 185-93.
18. Fijan S, Honigsmann H, Ortel B. Photodynamic therapy of epithelial skin tumors using delta aminolevulinic acid and desferrioxamine. Br. J. Dermatol. 1995; 133: 282-8.
19. Messman H, Knuchel R, Baumer W et al. Endoscopic fluorescence detection of dysplasia in patients with Barrett's esophagus, ulcerative colitis, or adenomatous polyps after 5-aminolevulinic acid-induced protoporphyrin IX sensitization. Gastrointest. Endosc. 1999; 49: 97-100.
20. Kapadia CR, Cutruzzola FW, O'Brien KM et al. Laser-induced fluorescence spectroscopy of human colonic mucosa: detection of adenomatous transformation. Gastroenterology 1990; 99: 150-7.
21. Richards-Kortum R, Rava RP, Fitzmaurice M et al. Spectroscopic diagnosis of colonic dysplasia. Photochem. Photobiol. 1991; 53: 777-86.
22. Schomacker KT, Frisoli JK, Compton CC et al. Ultraviolet laser-induced fluorescence of colonic polyps. Gastroenterology 1992; 102: 1155-60.
23. Cothren RM, Sivak MV, Van Dame J et al. Detection of dysplasia at colonoscopy using laser-induced fluorescence: A blinded study. Gastrointest. Endosc. 1996; 44: 168-76.
24. Panjehpour M, Overholt BF, Schmidhammer JL et al. Spectroscopic diagnosis of esophageal cancer: new classification model, improved measurement system. Gastrointest. Endosc. 1995; 41: 577-81.
25. Vo-Dinh T, Panjehpour M, Overholt BF, Farris C, Buckley FP III, Sneed R. In vivo cancer diagnosis of the esophagus using differential normalized fluorescence (DNF) indices. Lasers Surg. Med. 1995; 16: 41-7.
26. Bourg-Heckly G, Blais J, Padilla JJ, Bourdon O, Etienne J, Guillemin F, Lafay L. Endoscopic ultraviolet-induced autofluorescence spectroscopy of the esophagus: tissue characterization and potential for early cancer diagnosis. Endoscopy 2000; 32: 756-65.
27. Mycek MA, Schomacker KT, Nishioka NS. Colonic polyp differentiation using time-resolved autofluorescence spectroscopy. Gastrointest. Endosc. 1998; 48: 390-4.
28. Georgakoudi I, Jacobson BC, Van Dam J et al. Fluorescence, reflectance, and light-scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus. Gastroenterology 2001; 120: 1620-9.
29. Harries ML, Lam S, MacAulay C, Qu J, Palcic B. Diagnostic imaging of the larynx: autofluorescence of laryngeal tumours using the helium-cadmium laser. J. Laryngol. Otol. 1995; 109: 108-10.
30. Lam S, MacAulay C, LeRiche JC, Palcic B. Detection and localization of early lung cancer by fluorescence bronchoscopy. Cancer 2000; 89: 2468-73.
31. Wagnieres GA, Star WM, Wilson BC. In vivo fluorescence spectroscopy and imaging for oncological applications. Photochem. Photobiol. 1998; 68: 603-32.
32. Haringsma J, Tytgat GN, Yano H et al. Autofluorescence endoscopy: feasibility of detection of GI neoplasms unapparent to white light endoscopy with an evolving technology. Gastrointest. Endosc. 2001; 53: 642-50.
33. DaCosta RS, Wilson BC, Marcon NE. Light-induced fluorescence endoscopy of the gastrointestinal tract. Gastrointest. Endosc. Clin. North Am. 2000; 10: 37-69.
34. Yano H, Iishi H, Tatsuta M. Diagnosis of early gastric cancers by endoscopic autofluorescence imaging system Endoscopy 1996; 28: S29 (Abstract).
35. Messmann H, Kullmann F, Wild T et al. Detection of dysplastic lesions by fluorescence in a model of colitis in rats after previous photosensitization with 5-aminolaevulinic acid. Endoscopy 1998; 30: 333-8.
36. Bird RP. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995; 29: 55-71.
37. Takayama T, Katsuki S, Takahashi Y et al. Aberrant crypt foci of the colon as precursors of adenoma and cancer. N. Engl. J. Med. 1998; 339: 1277-84.
38. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardization classification with provisional clinical applications. Hum Pathol. 1983; 14: 931-68.
39. Messman H, Mikvy P, Montan S et al. Endoscopic and microscopic fluorescence studies in patients with ulcerative colitis after 5-aminolevulinic acid sensitization. Gastroenterology 1997; 108: A506 (Abstract).
40. van den Boogert J, Houtsmuller AB, de Rooij FWM et al. Kinetics, localization, and mechanism of 5-aminolevulinic acid-induced porphyrin accumulation in normal and Barrett's like rat esophagus. Laser Surg. Med. 1999; 24: 3-13.
41. Kriegmair M, Baumgartner R, Knuechel P et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994; 44: 836-41.
42. Leunig A, Rick K, Stepp H et al. Fluorescence imaging and spectroscopy of 5-aminolevulinic acid-induced protoporphyrin IX for the detection of neoplastic lesions of the oral cavity. Am. J. Surg. 1996; 172: 674-7.
43. Stummer WS, Stocker S, Wagner S et al. Intraoperative detection of malignant.glioma by 5-ALA induced porphyrin fluorescence. Neurosurgery 1998; 42: 518-26.
44. Peng Q, Berg K, Moan J et al. 5-Aminolevulinic acid-based photodynamic therapy-principles and experimental research. Photochem. Photobiol. 1997; 65: 235-51.
45. Marcus SL, Sobel RS, Golub AL et al. Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and developmental status. J. Clin. Laser Med. Surg. 1996; 14: 59-66.
46. Shim MG, Wilson BC. The effects of ex vivo handling procedures on the near-infrared Raman spectra of normal mammalian tissues. Photochem. Photobiol. 1996; 63: 662-71.
47. Hanlon EB, Manoharan R, Koo TW et al. Prospects for in vivo Raman spectroscopy. Phys. Med. Biol. 2000; 45: 1-59.
48. Shim MG, Wilson BC. Development of an in vivo Raman spectroscopic system for diagnostic applications. J. Raman Spectrosc. 1997; 28: 131-42.
49. Shim MG, Wilson BC, Marple E, Wach M. A study of fiberoptic probes for in vivo medical Raman spectroscopy. Appl. Spectrosc. 1999; 53: 619-27.
50. Nie S, Emory SR. Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science 1997; 275: 1102-6.
51. Bohorfoush AG. Tissue spectroscopy for gastrointestinal diseases. Endoscopy 1996; 28: 372-80.
52. Wallace MB, Perelman LT, Backman V et al. Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy. Gastroenterology 2000; 119: 677-82.
53. Backman V, Wallace MB, Perelman LT et al. Detection of preinvasive cancer cells. Nature 2000; 406: 35-6.
54. Rollins AM, Yazdanfar S, Barton JK, Izatt JA. Real-time in vivo color Doppler optical coherence tomography. J. Biomed. Opt. 2002; 7: 123-9.
55. Bouma BE, Tearnev GJ, Compton CC, Nishioka NS. High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography. Gastrointest. Endosc. 2000; 51: 467-74.
56. Pitris C, Jesser C, Boppart SA, Stamper D, Brezinski ME, Fujimoto JG. Feasibility of optical coherence tomography for high-resolution imaging of human gastrointestinal tract malignancies. J. Gastroenterol. 2000; 35: 87-92.
57. Sivak MV, Kobayashi Y, Izatt JA et al. High-resolution endoscopic imaging of the GI tract using optical coherence tomography. Gastrointest. Endosc. 2000; 51: 474-9.
58. Endo M, Sakakibara N, Suzuki H et al. Observation of esophageal lesions with the use of endoscopic dyes. Prog. Dig. Endosc. 1972; 1: 34.
59. Ina H, Shibuya H, Ohashi I et al. The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer: Screening results using Lugol dye endoscopy. Cancer 1994; 73: 2038-41.
60. Kudo S, Tamura S, Nakajima T, Yamano H, Kusaka H, Watanabe H. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest. Endosc. 1996; 44: 8-14.
61. Kudo S, Tamure S, Nakajima T et al. Depressed type of colorectal cancer. Endoscopy 1995; 27: 54-7.
62. Saitoh Y, Waxman I, West AB et al. Prevalence and distinctive biologic features of flat colorectal adenomas in a North American population. Gastroenterology 2001; 120: 1657-65.
63. Sharma P, Weston AP, Sampliner RE. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's esophagus. Gastrointest. Endosc. 2001; 53: AB62.
64. DaCosta R. Mechanisms of fluorescence endoscopy of the human colon. MSc Thesis, University of Toronto, Toronto, Ontario, Canada. 2000.
65. Inoue H, Igari T, Nishikage T, Ami K, Yoshida T, Iwai T. A novel method of virtual histopathology using laser-scanning confocal microscopy in-vitro with untreated fresh specimens from the gastrointestinal mucosa. Endoscopy 2000; 32: 439-43
66. Delaney PM, King RG, Lambert JR, Harris MR. Fibre optic confocal imaging (FOCI) for subsurface microscopy of the colon in vivo. J. Anat. 1994; 184: 157-60.
67. McLaren WJ, Anikijenko P, Thomas SG, Delaney PM, King RG. In vivo detection of morphological and microvascular changes of the colon in association with colitis using fiberoptic confocal imaging (foci). Dig. Dis. Sci. 2002; 4: 2424-33
68. Liang C, Sung KB, Richards-Kortum RR, Descour MR. Design of a high-numerical-aperture miniature microscope objective for an endoscopic fiber confocal reflectance microscope. Appl. Opt. 2002; 41: 4603-10.
69. Dickensheets DL, Kino GS. Micro-machined scanning confocal optical microscope. Opt. Lett. 1996; 21: 764-6.
70. Lane P, Dlugan ALP, Richards-Kortum R, MacAuley C. Fiber-optic confocal microscopy using a spatial light modulator. Opt. Lett. 2000; 25: 1780-82.
71. Lane P, Dlugan ALP, MacAuley C. DMD-enabled conofcal microscopy. In: Tuchin VV, Izatt JA, Fujimotto JG (eds) Coherence Domain Optical Methods in Biomedical Science and Clinical Applications V. 2001; Proceedings SPIE, January 2001, San Jose, CA Vol. 4251.
72. Reilly RM. Radioimmunotherapy of malignancies. Clin. Pharm. 1991; 10: 359-75.
73. Ballou B, Fisher GW, Hakala TR, Farkas DL. Tumor detection and visualization using cyanine fluorochrome-labeled antibodies. Biotechnol. Prog. 1997; 13: 649-58.
74. Haringsma J, Tytgat GNJ. Fluorescence and autofluorescence. Baillier's. Clin. Gastroenterol. 1999; 13: 1-10.
75. Pelegrin A, Folli S, Buchegger F, Mach JP, Wagnieres G, van den Bergh H. Antibody-fluorescein conjugates for photoimmunodiagnosis of human colon carcinoma in nude mice. Cancer 1991; 67: 2529-37.
76. Folli S, Westermann P, Braichotte D et al. Antibody-indocyanin conjugates for immunophotodetection of human squamous cell carcinoma in nude mice. Cancer Res. 1994; 54: 2643-9.
77. Gutowski M, Carcenac M, Pourquier D et al. Intraoperative immunophotodetection for radical resection of cancers: evaluation in an experimental model. Clin. Cancer Res. 2001; 7: 1142-8.
78. Kusaka Y, Ito S, Muguruma N et al. Vital immunostaining of human gastric and colorectal cancers grafted into nude mice: a preclinical assessment of a potential adjunct to videoendoscopy. J. Gastroenterol. 2000; 35: 748-52.
79. Nussbaum S, Roth HJ. Human anti-mouse antibodies: pitfalls in tumor marker measurement and strategies for enhanced assay robustness; including results with Elecsys CEA. Anticancer Res. 2000; 20: 5249-52.
80. Ramjiawan B, Maiti P, Aftanas A et al. Noninvasive localization of tumors by immunofluorescence imaging using a single chain Fv fragment of a human monoclonal antibody with broad cancer specificity. Cancer 2000; 89: 1134-44.
81. Yokota T, Milenic DE, Whitlow M, Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 1992; 52: 3402-8.
82. Wu A, Williams LE, Zieran L et al. Anti-carcinoembryonic antigen (CEA) diabody for rapid tumor targeting and imaging. Tumor Targeting 1999; 4: 47-58.
83. Weissleder R, Tung CH, Mahmood U, Bogdanov A Jr. In vivo imaging of tumours with protease activated near-infrared fluorescent probes. Nat. Biotechnol. 1999; 17: 375-8.
84. Marten K, Bremer C, Khazaie K, Sameni M, Sloane B, Tung CH, Weissleder R. Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice. Gastroenterology 2002; 122: 406-14.
85. DaCosta RS, Tang Y, Reilly RM, Wilson BC. In vivo imaging of colonic tumours with a near-infrared fluorescent probe targeted against a tumour-associated-mucin in a human colon cancer xenograft mouse model. Annual Meeting of the American Gastroenterology Association, Digestive Diseases Week Conference; May 2002, San Francisco, CA.
86. Maunoury V, Mordon S, Geboes K et al. Early vascular changes in Crohn's disease: an endoscopic fluorescence study. Endoscopy 2000; 32: 700-5.
87. Muguruma N, Ito S, Hayashi S et al. Antibodies labeled with fluorescence-agent excitable by infrared rays. J. Gastroenterol. 1998; 33: 467-71.
88. Bando T, Muguruma N, Ito S et al. Basic studies on a labeled anti-mucin antibody detectable by infrared-fluorescence endoscopy. J. Gastroenterol. 2002; 37: 260-9.
89. Hayashi S, Muguruma N, Bando T, Taoka S, Ito S, Ii K. Vital immunohistochemical staining for a novel method of diagnosing micro-cancer. Examination of immunohistochemical staining of non-fixed fresh tissue. J. Med. Invest. 1999; 46: 178-85.
90. Ito S, Muguruma N, Kusaka Y et al. Detection of human gastric cancer in resected specimens using a novel infrared fluorescent anti-human carcinoembryonic antigen (CEA) antibody with an infrared fluorescence endoscope in vitro. Endoscopy 2001; 33: 849-53.
91. Tatsuta M, Iishi H, Ichii M et al. Diagnosis of gastric cancers with fluorescein-labeled monoclonal antibodies to carcinoembryonic antigen. Lasers Surg. Med. 1989; 9: 422-6.
92. Keller R, Winde G, Eisenhawer C et al. Immunoscopy - a technique combining endoscopy and immunofluorescence for diagnosis of colorectal cancer. Gastrointest. Endosc. 1998; 47: 154-61.
93. Folli S, Wagnieres G, Pelegrin A et al. Immunophotodiagnosis of colon carcinomas in patients injected with fluoresceinated chimerical antibodies against carcinoembrionic antigen. Proc. Natl. Acad. Sci. USA 1992; 89: 7973-7.
94. Keller R, Winde G, Terpe HJ, Foerster EC, Domschke W. Fluorescence endoscopy using a fluorescein-labeled monoclonal antibody against carcinoembryonic antigen in patients with colorectal carcinoma and adenoma. Endoscopy 2002; 34: 801-7.
95. Krishnadath KK, Reid BJ, Wang KK. Biomarkers in Barrett esophagus. Mayo Clin. Proc. 2001; 76: 438-46.
96. Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer. Clin. Cancer Res. 2001; 7: 1118-26.
97. Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug. Chem. 2002; 13: 554-60.
98. Horisberger M. Colloidal gold: a cytochemical marker for light and fluorescent microscopy and for transmission and scanning electron microscopy. Scan Electron Microsc. 1981; Pt 2: 9-31.